FDA Warning Letter — Enrite

Case 624045 — FEI 3021166064

The FDA took a Warning Letter action against Enrite on Dec 28, 2021 (Manalapan, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Enrite
Date
Dec 28, 2021
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Manalapan, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.